IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tybourne Capital Management HK LTD

Portfolio Profile

CIK: 0001553936 | HONG KONG, K3

Investment Profile

Style

Growth

Turnover

High

Orientation

—
$30.9M
AUM
4
Positions
100%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Taysha Gene Therapies Inc (Tsha US)(TSHA)3,700,000$12.1M39.11%
2Forte Biosciences Inc (Fbrx US)(FBRX)786,647$11.8M38.15%
3Alumis Inc (Alms US)(ALMS)1,399,250$5.6M18.05%
4Zentalis Pharmaceuticals Inc (Zntl US)(ZNTL)961,486$1.5M4.69%

Sector Allocation

Latest filing, equity positions only

Healthcare100% · $30.9M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Consumer Cyclical6.05%0%-6.05%
Healthcare93.95%100%+6.05%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

Cap SizePrev %Curr %

AUM History

$1.0B | 27 pos.
$993.2M | 49 pos.
$925.3M | 49 pos.
$715.7M | 41 pos.
$671.2M | 39 pos.
$584.9M | 41 pos.
Change
Small Cap82.88%77.26%-5.62%
Mid Cap12.15%18.05%+5.9%
Micro Cap4.96%4.69%-0.27%
$491.7M | 40 pos.
$356.7M | 34 pos.
$398.4M | 37 pos.
$23.6M | 5 pos.
$34.5M | 6 pos.
$30.9M | 4 pos.
Q4
22
Q1
23
Q2
23
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25

Recent Activity

Quarter-over-quarter position changes

0
New
2
Closed
0
Increased
2
Decreased
2
Unchanged